程体娟,覃红,张培棪.凤翔乙肝康胶囊对实验性肝损伤的保护作用[J].,1994,(3):162-164,134 |
凤翔乙肝康胶囊对实验性肝损伤的保护作用 |
Protection Against Experimental Hepatic Injury by Fengxiang Yigankang Capsule |
|
DOI: |
中文关键词: 凤翔乙肝康 丙氨酸氨基转移酶 丙二醛 还原型谷胱甘肽 脂肪变性 |
英文关键词:Fengxiang Yigankang capsule serum alanine aminotranoferase malonicaldehyde glutathione fatty degeneration |
基金项目: |
|
Hits: 1392 |
Download times: 901 |
中文摘要: |
用四氯化碳(CCl4)和扑热息痛(AAP)造成的小鼠肝损伤模型,观察凤翔乙肝康胶囊对肝损伤的影响。结果表明:该药能对抗CCl4和AAP所致肝脏丙二醛(MDA)的升高和还原型谷胱甘肽(GSH)的耗竭。凤翔乙肝康0.45g/kg还能降低血清丙氨酸氨基转移酶(SALT)的活力(P<0.05)。组织形态学观察表明:凤翔乙肝康0.45、0.9和1.8g/kg均能明显减轻CCl4所致肝脂肪变性(P<0.05)。 |
英文摘要: |
Pectective effect of Fengxiang Yigankang(FXYGK)capsule against hepatotoxicity induced by CCI.and acetaminophen(AAP)was studied.It was found that the FXYGK capsule inhibited markedly malonic aldehyde(MDA)formation of liver induced by CCl4 and AAP.It blocked also depletion of reduced form of glutathione(GSH)of damaged liver induced by AAP.In addition,FXYGK could decrease serum alanine aminotransferase levels induced by CCl4(P<0.05).The results of histopathological examination showed that the FXYGK capsule(0.45,0.9 and 1.8 g/kg)could also reduce significantly fatty degeneration of liver(P<0.05). |
View Full Text View/Add Comment Download reader |